Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly BioMedicines Head Ricks Tasked With Overseeing Growth Phase As Next CEO

Jul 28 2016

• By Jessica Merrill

Related Content

Lilly, Anthem Singing Same Tune On Value-Based Pricing, Communication Policy

Feb 09 2016

No Big Surprises From Lilly: Management Sticks To Its Guns On Strategy

Jun 30 2011

Timeline At The Top: What Witty Did At GSK

Mar 17 2016

FDA OK's Lilly's Taltz; Rival To Novartis' Cosentyx

Mar 23 2016

Lilly Awaits New Rewards For SGLT-2 Diabetes Drug Jardiance

Jul 27 2016

Lilly CEO Lechleiter On Drug Pricing: ''The Facts Tell Us A Different Story''

Oct 23 2015

Despite CETP Loss, Lilly Says Long-Term Strategy Is Starting To Bear Fruit

Oct 26 2015

Scangos Leaves Biogen Transformed And Transitioning

Jul 21 2016

Novartis Rejiggers Pharma To Favor Oncology

May 18 2016

Related Companies

Eli Lilly and Company

Johnson & Johnson

Anthem Inc.

GSK plc

Biogen, Inc.

Novartis AG

Additional Topics

Leadership Companies BioPharmaceutical

More from Leadership

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window